Genetic mutagenesis has been used to study the roles of ras oncogenes and protooncogenes in cell transformation and normal cellular function. A very potent dominant negative ras mutant (asparagine-116 to tyrosine mutation of the v-H-ras) has been identified and characterized. This 116Y mutant strongly inhibits the c-H-ras proto-oncogene function. It suppresses transformation induced by over-expression of c-H-ras proto-oncogene function. It suppresses transformation by a group of retroviruses carrying a variety of protein-tyrosine kinase oncogenes, including v-abl, v- fes/flp, v-src and v-fms. Surprisingly, transformation by retroviruses carrying the homologous ras oncogenes, including v-H- ras, v-K-ras and v-bas, is not affected. These results suggest blocking of a c-ras proto-oncogene function upstream to transformation induced by the activated ras oncogenes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CP004963-15
Application #
3853406
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
United States
Zip Code